BeyondSpring Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)
In: Contify Life Science News, 2021-06-01, S. 4
Zeitungsartikel
Zugriff:
Titel: |
BeyondSpring Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)
|
---|---|
Link: | |
Zeitschrift: | Contify Life Science News, 2021-06-01, S. 4 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|